Deutsche Bank Ag\ Puma Biotechnology, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.64 - $3.3 $30,300 - $60,970	-18,476 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.13 - $3.24 $4,426 - $6,732	-2,078 Reduced 10.11%	18,476 $53,000
Q4 2021 Feb 11, 2022	SELL	$2.85 - $6.58 $165 - $381	-58 Reduced 0.28%	20,554 $63,000
Q3 2021 Nov 04, 2021	SELL	$6.63 - $9.39 $82,483 - $116,820	-12,441 Reduced 37.64%	20,612 $145,000
Q2 2021 Aug 11, 2021	BUY	$8.98 - $11.6 $61,701 - $79,703	6,871 Added 26.24%	33,053 $303,000
Q1 2021 May 13, 2021	SELL	$9.38 - $13.63 $17,568 - $25,528	-1,873 Reduced 6.68%	26,182 $254,000
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $2.68 Million - $4.18 Million	-344,202 Reduced 92.46%	28,055 $288,000
Q3 2020 Nov 12, 2020	SELL	$9.5 - $11.14 $2.58 Million - $3.02 Million	-271,080 Reduced 42.14%	372,257 $3.76 Million
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $681,925 - $1.29 Million	97,279 Added 17.81%	643,337 $6.71 Million
Q1 2020 May 14, 2020	SELL	$6.28 - $14.57 $883,589 - $2.05 Million	-140,699 Reduced 20.49%	546,058 $4.61 Million
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $6,032 - $9,957	-928 Reduced 0.13%	686,757 $6.01 Million
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $2.54 Million - $3.72 Million	-289,799 Reduced 29.65%	687,685 $7.4 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $7.15 Million - $20.8 Million	580,997 Added 146.54%	977,484 $12.4 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $2.09 Million - $4.26 Million	-100,548 Reduced 20.23%	396,487 $15.4 Million
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $5.75 Million - $13.4 Million	286,385 Added 135.95%	497,035 $10.1 Million
Q3 2018 Dec 21, 2021	BUY	$41.2 - $59.85 $4.03 Million - $5.85 Million	97,714 Added 86.52%	210,650 $9.66 Million
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $1.38 Million - $2.01 Million	-33,584 Reduced 22.92%	112,936 $5.18 Million
Q2 2018 Apr 21, 2020	BUY	$48.3 - $68.25 $876,741 - $1.24 Million	18,152 Added 14.14%	146,520 $8.67 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $7.06 Million - $9.98 Million	-146,272 Reduced 53.26%	128,368 $7.59 Million
Q1 2018 Oct 18, 2019	BUY	$59.7 - $99.25 $3.79 Million - $6.3 Million	63,525 Added 30.09%	274,640 $18.7 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $3.4 Million - $5.64 Million	-56,871 Reduced 21.22%	211,115 $14.4 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $31.5 Million - $44.5 Million	-335,922 Reduced 55.62%	267,986 $26.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $43.5 Million - $72.3 Million	603,908	603,908 $72.3 Million

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.7 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.19 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.64 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.91 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account